WakeUp was recognised for its ability in naturally helping employees during work hours. Following four years of research, including three clinical studies and successful local sales to multi-national high-tech companies, Inno-Bev believes that WakeUp is ready to present strategic opportunities with global convenience and health brands.
Eli Faraggi, creator of WakeUp, is said to have designed his beverage formula as a next-generation solution for the US$40 billion (and rapidly growing) energy drink industry.
“We are very proud to receive this award for innovation,” said Faraggi. “While energy drink sales are on the rise, we believe there is a growing demand for safe, science-based alternatives to the existing caffeine-based beverages that are under review by the FDA and in Europe. Consumer beverage brands can take advantage of our science, either on their labels or by advertizing the benefits of WakeUp, all in accordance with evolving regulatory requirements.”
WakeUp (often called a “post lunch waker”) is a 100ml, lemongrass-flavoured, daily beverage designed to provide a comprehensive solution for the fatigue that occurs during noon time and is known as "post lunch dip" syndrome (P.L.D.). The WakeUp formulation is patent-protected and based on natural standardised ingredients already used in nutritional foods and beverages, including guarana, ginkgo biloba, elderberry and a unique apple sugar with a low glycaemic index that reduces sugar fluctuation.
WakeUp’s safety and efficacy are said to have have been scientifically demonstrated in three clinical trials at two institutions: the Rambam Health Care Campus and the Technion (Israel Institute of Technology) medical faculty.
Eli Faraggi, creator of WakeUp, is said to have designed his beverage formula as a next-generation solution for the US$40 billion (and rapidly growing) energy drink industry.
“We are very proud to receive this award for innovation,” said Faraggi. “While energy drink sales are on the rise, we believe there is a growing demand for safe, science-based alternatives to the existing caffeine-based beverages that are under review by the FDA and in Europe. Consumer beverage brands can take advantage of our science, either on their labels or by advertizing the benefits of WakeUp, all in accordance with evolving regulatory requirements.”
WakeUp (often called a “post lunch waker”) is a 100ml, lemongrass-flavoured, daily beverage designed to provide a comprehensive solution for the fatigue that occurs during noon time and is known as "post lunch dip" syndrome (P.L.D.). The WakeUp formulation is patent-protected and based on natural standardised ingredients already used in nutritional foods and beverages, including guarana, ginkgo biloba, elderberry and a unique apple sugar with a low glycaemic index that reduces sugar fluctuation.
WakeUp’s safety and efficacy are said to have have been scientifically demonstrated in three clinical trials at two institutions: the Rambam Health Care Campus and the Technion (Israel Institute of Technology) medical faculty.
